Page last updated: 2024-08-22

hypochlorous acid and 4-hydroxyphenylacetaldehyde

hypochlorous acid has been researched along with 4-hydroxyphenylacetaldehyde in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hazen, SL; Hegele, RA; Heinecke, JW; Huff, MW; Miller, DB; Whitman, SC	1
Alt, E; Exner, M; Gmeiner, B; Hermann, M; Hofbauer, R; Kapiotis, S; Minar, E; Quehenberger, P; Speiser, W	1

Other Studies

2 other study(ies) available for hypochlorous acid and 4-hydroxyphenylacetaldehyde

Article	Year
Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:5 Topics: Acetaldehyde; Animals; Apolipoproteins E; Arteriosclerosis; Cell Line; Cholesterol Esters; Esterification; Humans; Hyperlipoproteinemia Type III; Hypochlorous Acid; Interferon-gamma; Lipoprotein Lipase; Lipoproteins, VLDL; Macrophages; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Peroxidase; Phenol; Poly I; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class A; Scavenger Receptors, Class B; Sterol O-Acyltransferase; Triglycerides; Tyrosine	1999
p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL. FEBS letters, 2001, Feb-09, Volume: 490, Issue:1-2 Topics: Acetaldehyde; Antioxidants; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Endothelium, Vascular; Free Radical Scavengers; Humans; Hydrogen-Ion Concentration; Hypochlorous Acid; Ions; Lipid Metabolism; Lipoproteins, LDL; Neutrophils; Oxygen; Peroxidase; Phenol; Protein Binding; Thiobarbituric Acid Reactive Substances; Time Factors; Tyrosine; Umbilical Veins	2001

Article

Year

Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages.

Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:5

Topics: Acetaldehyde; Animals; Apolipoproteins E; Arteriosclerosis; Cell Line; Cholesterol Esters; Esterification; Humans; Hyperlipoproteinemia Type III; Hypochlorous Acid; Interferon-gamma; Lipoprotein Lipase; Lipoproteins, VLDL; Macrophages; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Peroxidase; Phenol; Poly I; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class A; Scavenger Receptors, Class B; Sterol O-Acyltransferase; Triglycerides; Tyrosine

1999

p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.

FEBS letters, 2001, Feb-09, Volume: 490, Issue:1-2

Topics: Acetaldehyde; Antioxidants; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Endothelium, Vascular; Free Radical Scavengers; Humans; Hydrogen-Ion Concentration; Hypochlorous Acid; Ions; Lipid Metabolism; Lipoproteins, LDL; Neutrophils; Oxygen; Peroxidase; Phenol; Protein Binding; Thiobarbituric Acid Reactive Substances; Time Factors; Tyrosine; Umbilical Veins

2001